Trends in the growing impact of group A Streptococcus infection on public health after COVID-19 pandemic: a multicentral observational study in Okayama, Japan
Authors:
Open Access
- 16 December 2024
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 44 (2) , 383-391
Abstract
Purpose: Following the COVID-19 pandemic, group A Streptococcus (GAS) infection has been surging worldwide. We aimed to compare the disease burden between notified cases of streptococcal toxic shock syndrome (STSS) and unreported GAS infections. Methods: This is a multicentral observational study, retrospectively performed at seven hospitals in Okayama prefecture in Japan from January 2022, to June 2024. Clinical and microbiological data of patients with positive cultures of GAS were collected from the medical records. Primary outcomes were defined as rates of surgical procedures, intensive care unit (ICU) admission, and in-hospital mortality, which were compared among patients with locally-defined STSS, invasive GAS (iGAS), and non-iGAS infection. Results: GAS was detected in 181 patients, with 154 active cases of GAS infection. The number of patients with GAS infection surged in late 2023. The most common source of infection was skin and soft tissue infections, accounting for 83 cases, including 15 cases of necrotizing fasciitis, and 12 cases (7.8%) were notified to public health authorities as STSS. Among the 25 unreported iGAS cases, 9 (36.0%) underwent surgical intervention, and 4 patients (16.0%) required ICU admission. The mortality rates in the unreported iGAS cases were comparable to those observed in the notified STSS. Conclusions: We highlighted that the number of iGAS infections was twofold higher than that of notified STSS, with comparable mortality rate between these groups, indicating substantial underestimation of the true burden of iGAS. This epidemiological investigation has significant implications for enhancing infectious disease surveillance frameworks and public health policy development.Keywords
Funding Information
- Okayama University
This publication has 22 references indexed in Scilit:
- COVID-19 complicated with severe M1UK-lineage Streptococcus pyogenes infection in elderly patients: A report of two casesInternational Journal of Infectious Diseases, 2024
- Increasing reports of streptococcal toxic shock syndrome from JapanNew Microbes and New Infections, 2024
- Rapid expansion and international spread of M1UK in the post-pandemic UK upsurge of Streptococcus pyogenesNature Communications, 2024
- Population of invasive group A streptococci isolates from a German tertiary care center is dominated by the hypertoxigenic virulent M1UK genotypeInfection, 2023
- Detection of Streptococcus pyogenes M1UK in Australia and characterization of the mutation driving enhanced expression of superantigen SpeANature Communications, 2023
- Increase of emm1 isolates among group A Streptococcus strains causing scarlet fever in Shanghai, ChinaInternational Journal of Infectious Diseases, 2020
- Emergence of dominant toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a population-based molecular epidemiological studyThe Lancet Infectious Diseases, 2019
- Increased prevalence of group A streptococcus isolates in streptococcal toxic shock syndrome cases in Japan from 2010 to 2012Epidemiology and Infection, 2014
- Severe group a streptococcal infection and streptococcal toxic shock syndromeCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2000
- Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections1993